FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Tositumomab and Iodine I 131 Tositumomab (Bexxar)
Status: Discontinuation
»Therapeutic Categories: Oncology

GlaxoSmithKline (Revised 02/18/2014)

Company Contact Information:
888-825-5249

Presentation Posting Date Related Information
N/A 02/18/2014
http://hospiraadvancewithus.com/

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English